Fig. 4

Immunohistochemistry in representative slides of the patient’s primary tumor and xenograft tumor through the generations. The tumor cells of xenografts maintained the key immunophenotype of the patient’s gliomas. There was also decreased GFAP expression and increased vimentin expression over the generations